Let's see how we do on the next pandemic if we screw the IP out of all of the producers who stepped up to produce a vaccine.

If the scenario is that they'd still have their mRNA IP if they had decided not to make a vaccine, that is not the incentive structure we want to setup.

It's also not where the constraint lies.